Search

everythinglearnresearchcommunity

for

Search:↓

Mechlorethamine treatment regrew hair in mice by killing immune cells causing hair loss without harming hair follicles.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Symmetrical Acrokeratoderma (SAK) may be a unique skin condition in China, lacking specific treatment and needing long-term monitoring.

Topical diphencyprone helped regrow hair in mice and rats with a condition similar to human hair loss.

Patients with RASopathies are at risk for autoimmune disorders and should be routinely screened.

Microinflammation is more intense in smaller hair follicles and may be linked to hair loss.

Antroquinonol may help prevent skin depigmentation by suppressing certain immune cells.

JAK inhibitors may help treat Alopecia Areata but need careful monitoring due to side effects.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Rare changes in the KRT82 gene are linked to a higher risk of Alopecia Areata.

Finasteride can cause a unique skin reaction on the penile shaft.

A man was diagnosed with a rare form of lupus after showing unique skin symptoms that responded well to treatment.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

Autoimmune reactions may cause both alopecia areata and HAM.

Talc in street cocaine can cause immune-reactive skin nodules where injected.

HTLV-1-associated lichenoid dermatitis (HALD) is linked to an immune response against HTLV-1-infected cells.

A new mouse model for vitiligo helps study immune responses and potential treatments.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Astragalus membranaceus helps regrow hair and reduce hair loss symptoms.

Autoimmune hair loss may be linked to increased Th1 and Th17 cells and decreased Th2 cells.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

ILC1 cells contribute to hair loss in alopecia areata.

Targeting CXCL10 may help treat alopecia areata.

A patient's skin rash did not affect the area where a previous viral rash was healing, suggesting a rare immune response.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Specific immune cells cause alopecia areata and blocking certain proteins can prevent it.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

The patient with both scarring and non-scarring hair loss showed complex immune reactions and improved with steroid treatment.